Skye Bioscience, Inc. Other Current Liabilities
Skye Bioscience, Inc. (SKYE) had Other Current Liabilities of $966.12 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $966.12K.
- 2026-03-31: Other Liabilities, Current $3.35M.
- 2025-12-31: Other Liabilities, Current $2.64M.
- 2025-09-30: Other Liabilities, Current $2.37M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $966.12K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.35M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $2.64M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.37M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.22M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $847.85K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $654.20K 10-K · filed 2026-03-10 | |
| 2024-09-30 | $2.07M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.18M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $3.18M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $998.55K 10-Q · filed 2024-11-07 | |
| 2023-09-30 | $921.55K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $849.33K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $801.13K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $1.37M 10-Q · filed 2023-11-14 | $1.42M 10-K · filed 2023-03-31 |
| 2021-12-31 | $375.84K 10-K · filed 2023-03-31 | |
| 2020-12-31 | $197.56K 10-K · filed 2022-03-28 | $259.11K 10-K · filed 2021-03-02 |
| 2019-12-31 | $420.41K 10-K · filed 2021-03-02 | |
| 2018-12-31 | $184.46K 10-K · filed 2020-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |